Ulcerated infantile hemangiomas may present a therapeutic challenge, especially if there is concurrent hemorrhage or infection. The aim of this study was to systematically review the published evidence on the treatment of ulcerated hemangiomas, focusing on wound healing as the outcome of interest. We searched MEDLINE, Embase, SCOPUS, Cumulative Index to Nursing and Allied Health Literature (CINAHL), and Web of Science from inception to July 2016. Seventy-seven studies met our inclusion criteria. One study was a randomized controlled trial, 30 were observational studies, and 46 were case reports or case series. There is significant heterogeneity among the methods used. We reviewed 1239 patients in total. Of the 197 treated with oral propranolol, 191 (97.0%) achieved complete ulcer healing. Thirty-one patients failed corticosteroid therapy (oral, intralesional, or topical) and were subsequently successfully treated with other therapies. Surgical resections were typically performed for larger hemangiomas and those causing complications. None of the therapies discussed appear to offer significant advantages over others. Therefore, treatment decisions should be individualized based on location of disease, extent, symptoms, feasibility, cost, and parental preference.
KimLHCHogelingMWargonOJiwaneAAdamsS. Propranolol: useful therapeutic agent for the treatment of ulcerated infantile hemangiomas. J Pediatr Surg. 2011;46(4):759-763.
3.
PandeyAGangopadhyayANSharmaSPKumarVGopalSCGuptaDK.Conservative management of ulcerated haemangioma: twenty years experience. Int Wound J. 2009;6(1):59-62.
4.
ChangCSKangGC.Efficacious healing of ulcerated infantile hemangiomas using topical timolol. Plast Reconstr Surg Glob Open. 2016;4(2):e621.
MaguinessSMHoffmanWYMcCalmontTHFriedenIJ.Early white discoloration of infantile hemangioma: a sign of impending ulceration. Arch Dermatol. 2010;146(11):1235-1239.
7.
TiwariPPandeyVGangopadhyayANSharmaSPGuptaDK.Role of propranolol in ulcerated haemangioma of head and neck: a prospective comparative study. Oral Maxillofac Surg. 2016;20(1):73-77.
8.
Saint-JeanMLeaute-LabrzeCMazereeuw-HautierJet al. Propranolol for treatment of ulcerated infantile hemangiomas. J Am Acad Dermatol. 2011;64(5):827-832.
9.
Betlloch-MasIMartínez-MiraveteMTLucas-CostaAMartinAILSelva-OtalaurruchiJ.Outpatient treatment of infantile hemangiomas with propranolol: a prospective study. Actas Dermosifiliográficas. 2012;103(9):806.
10.
GulatiRJuryC.Propranolol for ulcerated haemangioma in a preterm baby: our experience. Br J Dermatol. 2010;163:126.
11.
MoraisPMaginaSMateusMTrindadeEJesusJMAzevedoF.Efficacy and safety of propranolol in the treatment of parotid hemangioma. Cutan Ocular Toxicol. 2011;30(3):245-248.
CavalliRBuffonRBDe SouzaMColliAMGelmettiC.Tumor lysis syndrome after propranolol therapy in ulcerative infantile hemangioma: rare complication or incidental finding?Dermatology. 2012;224(2):106-109.
14.
MousaWKuesKHaasEet al. Successful treatment of a large hemangioma with propranolol. J German Soc Dermatol. 2010;8(3):184-186.
15.
PavlakovicHKietzSLauererPZuttMLakomekM.Hyperkalemia complicating propranolol treatment of an infantile hemangioma. Pediatrics. 2010;126(6):e1589-e1593.
16.
JiYWangQChenSet al. Oral atenolol therapy for proliferating infantile hemangioma: a prospective study. Medicine (Baltimore). 2016;95(24):e3908.
17.
RuitenbergGYoung-AfatDAde GraafMPasmansSGBreugemCC.Ulcerated infantile haemangiomas: the effect of the selective beta-blocker atenolol on wound healing. Br J Dermatol. 2016;175(6):1357-1360.
18.
TanSTItinteangTDayDJO’DonnellCMathyJALeadbitterP.Treatment of infantile haemangioma with captopril. Br J Dermatol. 2012;167(3):619-624.
19.
CollinsSMBolgerTCondonCIrvineADWatsonR.Treatment of ulcerated haemangiomas with recombinant human platelet-derived growth factor. Br J Dermatol. 2004;151(1):260-260.
20.
MetzBJRubensteinMCLevyMLMetryDW.Response of ulcerated perineal hemangiomas of infancy to becaplermin gel, a recombinant human platelet-derived growth factor. Arch Dermatol. 2004;140(7):867-870.
21.
SugarmanJLMauroTMFriedenIJSiegfriedE.Treatment of an ulcerated hemangioma with recombinant platelet-derived growth factor. Arch Dermatol. 2002;138(3):314-316.
22.
MascarenhasRGuioteVAgroJHenriqueM.Ulcerated infantile hemangioma treated with imiquimod. Dermatol Online J. 2011;17(9):13.
23.
FawcettSLGrantIHallPNKelsallAWRNicholsonJC.Vincristine as a treatment for a large haemangioma threatening vital functions. Br J Plast Surg. 2004;57(2):168-171.
24.
AchauerBMVander KamVM.Ulcerated anogenital hemangioma of infancy. Plast Reconstr Surg. 1991;87(5):861-868.
25.
SerenaT.Wound closure and gradual involution of an infantile hemangioma using a noncontact, low-frequency ultrasound therapy. Ostomy Wound Manage. 2008;54(2):68-71.
26.
IllumNKarlsmarkTSvejgaardEUllmanSYssingM.Ulcerated haemangioma successfully treated with interferon alfa-2b and topical granulocyte-macrophage colony-stimulating factor. Dermatology. 1995;191(4):315-317.
27.
LawsPMPorterWTaibjeeSMClaytonTH.Topical breast milk may promote healing of ulceration in infantile haemangiomas. Clin Exp Dermatol. 2012;37(8):915-916.
28.
ThomasJKumarPKumarDD.Ulcerated infantile haemangioma of buttock successfully treated with topical timolol. J Cutan Aesthetic Surg. 2013;6(3):168-169.
29.
WatanabeSTakagiSSatoYHosakaY.Early surgical intervention for Japanese children with infantile hemangioma of the craniofacial region. J Craniofac Surg. 2009;20(suppl 1):707-709.
30.
FoxCMJohnsonBStoreyKDas GuptaRKimbleR.Negative pressure wound therapy in the treatment of ulcerated infantile haemangioma. Pediatr Surg Int. 2015;31(7):653-658.
31.
WeibelLBaryschMJScheerHSet al. Topical timolol for infantile hemangiomas: evidence for efficacy and degree of systemic absorption. Pediatr Dermatol. 2016;33(2):184-190.
32.
LiYHuYLiHDengL.Successful treatment of ulcerated hemangiomas with a dual-wavelength 595- and 1064-nm laser system. J Dermatolog Treat. 2016;27(6):562-567.
33.
HermosaEBoixedaPUrechMTurrionLPerezBJaenP.Treatment of ulcerated infantile hemangiomas with pulsed dye laser and Nd:YAG laser. Lasers Surg Med. 2014;46(4):360-361.
34.
MorelliJGTanOTYohnJJWestonWL.Treatment of ulcerated hemangiomas infancy. Arch Pediatr Adolesc Med. 1994;148(10):1104-1105.
35.
JorgeBFDel PozoJCastineirasIMazairaMFernandez-TorresRFonsecaE.Treatment of ulcerated haemangiomas with a non-coherent pulsed light source: brief initial clinical report. J Cosmet Laser Ther. 2008;10(1):48-51.
36.
LacourMSyedSLinwardJHarperJI.Role of the pulsed dye laser in the management of ulcerated capillary haemangiomas. Arch Dis Child. 1996;74(2):161-163.
37.
Theologie-LygidakisNSchoinohoritiOKTzerbosFIatrouI.Surgical management of head and neck vascular anomalies in children: a retrospective analysis of 42 patients. Oral Surg Oral Med Oral Pathol Oral Radiol. 2014;117(1):e22-31.
38.
NakadaKKawadaTFujiokaTet al. Hemangioma of the upper arm associated with massive hemorrhage in a neonate. Surg Today. 1993;23(3):273-276.
39.
ZhuZYangXZhaoYFanHYuMTopazM.Early surgical management of large scalp infantile hemangioma using the TopClosure Tension-Relief System. Medicine. 2015;94(47):e2128.
40.
AlterGJTrengove-JonesG, H Jr CE. Hemangioma of penis and scrotum. Urology. 1993;42(2):205-208.
41.
BookoutKMcCordSMcLaneKDoughtyD.Case studies of an infant, a toddler, and an adolescent treated with a negative pressure wound treatment system. J Wound Ostomy Continence Nurs. 2004;31(4):184-192 189p.
42.
PittaGBBGomesRR.Treatment of ulcerated hemangioma: case report. J Vasc Bras. 2009;8(3):263-266.
43.
OranjeAPde Waard-van der SpekFBDevillersACde LaatPCMadernGC.Treatment and pain relief of ulcerative hemangiomas with a polyurethane film. Dermatology (Basel, Switzerland). 2000;200(1):31-34.
44.
LapidothMBen-AmitaiDBhandarkarSFriedLArbiserJL.Efficacy of topical application of eosin for ulcerated hemangiomas. J Am Acad Dermatol. 2009;60(2):350-351.
45.
CanteVPham-LedardAImbertEEzzedineKLeaute-LabrezeC.First report of topical timolol treatment in primarily ulcerated perineal haemangioma. Arch Dis Child. 2012;97(2):F155-F156.
46.
NeriIVirdiALa PlacaMPatriziA.A perineal infantile haemangioma presenting as early ulcerations. Arch Dis Child. 2015;100(5):F393.
47.
HongEFischerG.Propranolol for recalcitrant ulcerated hemangioma of infancy. Aust J Dermatol. 2011;52:29.
48.
BarlowRJWalkerNPMarkeyAC.Treatment of proliferative haemangiomas with the 585 nm pulsed dye laser. Br J Dermatol. 1996;134(4):700-704.
49.
DavidLRMalekMMArgentaLC.Efficacy of pulse dye laser therapy for the treatment of ulcerated haemangiomas: a review of 78 patients. Br J Plast Surg. 2003;56(4):317-327.
50.
WardJFFriedlanderSFKaplanGW.Hemangioma presenting as an ulceration of the scrotum. J Urol. 1998;160(1):182-183.
51.
YanAC.Pain management for ulcerated hemangiomas. Pediatr Dermatol. 2008;25(6):586-589.
52.
HatfieldSJWrightAL.Becaplermin gel, a recombinant human platelet-derived growth factor, in the treatment of an ulcerated perineal haemangioma. Br J Dermatol. 2006;155:46-46.
53.
HasanQTanSTGushJPetersSGDavisPF.Steroid therapy of a proliferating hemangioma: histochemical and molecular changes. Pediatrics. 2000;105(1, pt 1):117-120.
54.
HoNTLansangPPopeE.Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study. J Am Acad Dermatol. 2007;56(1):63-68.
BoosMDCastelo-SoccioL.Experience with topical timolol maleate for the treatment of ulcerated infantile hemangiomas (IH). J Am Acad Dermatol. 2016;74(3):567-570.
57.
TlouganBEGonzalezMEOrlowSJ.Abortive segmental perineal hemangioma. Dermatol Online J. 2011;17(10).
58.
Al DosariSRiadH. Ulcerated nasal infantile haemangioma treated by oral propranolol. Dermatol Online J. 2013;19(5):18298.
59.
BagazgoitiaLTorreloAGutierrezJCLet al. Propranolol for infantile hemangiomas. Pediatr Dermatol. 2011;28(2):108-114.
60.
Ben-ZviGTGassJK.Propranolol for ulcerating infantile haemangiomas. Br J Dermatol. 2013;168(1):e5.
61.
Bernabeu-WittelJPereyra-RodriguezJJMantrana-BermejoMEFernandez-PinedaIDe AgustinJCConejo-MirJ.Propranolol for the treatment of severe hemangiomas of infancy: Results from a series of 28 patients. Actas Dermosifiliograficas. 2011;102(7):510-516.
62.
BourasMDehbiFElfatouakiFZet al. Propranolol therapy for infantile haemangiomas: a case series of 33 infants. J Am Acad Dermatol. 2013;68(4)(suppl 1):AB5.
63.
GidarisDEconomouMHatzidemetriouVGombakisNAthanassiou-MetaxaM.Use of propranolol in infantile haemangiomas: report of five cases and review of the literature. Hippokratia. 2011;15(1):81-83.
64.
HermansDJvan BeynumIMSchultze KoolLJvan de KerkhofPCWijnenMHvan der VleutenCJ.Propranolol, a very promising treatment for ulceration in infantile hemangiomas: a study of 20 cases with matched historical controls. J Am Acad Dermatol. 2011;64(5):833-838.
65.
LanoelATosiVBocianMet al. Perianal ulcers on a segmental hemangioma with minimal or arrested growth. Actas Dermosifiliograficas. 2012;103(9):820-823.
66.
NaouriMSchillTMaruaniABrossFLoretteGRosslerJ.Successful treatment of ulcerated haemangioma with propranolol. J Eur Acad Dermatol Venereol. 2010;24(9):1109-1112.
67.
NelsonSZimmermanKAlexanderJHennessyJSidmanJ.Outpatient propranolol is safe and effective in infants with hemangioma: single center experience and case report of successful use in a seven-year-old. Pediatr Blood Cancer. 2011;56(6):965.
68.
OksiutaMMatuszczakEDebekWDzienis-KoronkiewiczEHermanowiczA.Treatment of rapidly proliferating haemangiomas in newborns with propranolol and review of the literature. J Matern Fetal Neonatal Med. 2016;29(1):64-68.
69.
SaaiqMAshrafBSiddiquiSAhmadSSalman ZaibM.Successful propranolol treatment of a large size infantile hemangioma of the face causing recurrent bleeding and visual field disruption. World J Plast Surg. 2015;4(1):79-83.
70.
SadykovRRPodmelleFSadykovRAKasimovaKRMetellmannHR.Use of propranolol for the treatment infantile hemangiomas in the maxillofacial region. Int J Oral Maxillofac Surg. 2013;42(7):863-867.
71.
SansVDumas-De-la-roqueEBoraleviFet al. Propranolol for severe infantile haemangiomas. Br J Dermatol. 2009;161:117-118.
72.
SharmaVKFraulin FOG, DumestreDOWalkerLHarropAR.Beta-blockers for the treatment of problematic hemangiomas. Can J Plast Surg. 2013;21(1):23-28.
73.
ThomasJKumarPKumarDD.Ulcerated infantile haemangioma of leg successfully treated with propranolol. J Cutan Aesthetic Surg. 2011;4(3):211-213.
74.
VercellinoNRomaniniMVPelegriniMRiminiAOccellaCDalmonteP.The use of propranolol for complicated infantile hemangiomas. Int J Dermatol. 2013;52(9):1140-1146.
75.
StrandMSmidtAC.Pain management for ulcerated infantile hemangiomas. Pediatr Dermatol. 2012;29:124-126.
76.
Di MaioLBaldiADimaioVBarziA. Use of flashlamp-pumped pulsed dye laser in the treatment of superficial vascular malformations and ulcerated hemangiomas. In Vivo. 2011;25(1):117-123.
77.
MoraisPMaginaSReisAet al. Reticular hemangioma of the lower extremity associated with congenital structural anomalies: therapeutic approach. Medicina Cutanea Ibero-Latino-Americana. 2013;41(1):38-42.
78.
Rodríguez-RuizMTelladoMGdel Pozo LosadaJ.Combination of pulsed dye laser and propranolol in the treatment of ulcerated infantile haemangioma [in Spanish]. An Pediatr (Barc). 2016;84(2):92-96.
79.
Kunzi-RappK.Topical propranolol therapy for infantile hemangiomas. Pediatr Dermatol. 2012;29(2):154-159.
80.
ThomasRFHornungRLManningSCPerkinsJA.Hemangiomas of infancy - Treatment of ulceration in the head and neck. Arch Facial Plast Surg. 2005;7(5):312-315.
81.
McCuaigCCCohenLPowellJet al. Therapy of ulcerated hemangiomas. J Cutan Med Surg. 2013;17(4):233-242.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
